212 related articles for article (PubMed ID: 23179659)
21. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes.
Cowie CC; Port FK; Wolfe RA; Savage PJ; Moll PP; Hawthorne VM
N Engl J Med; 1989 Oct; 321(16):1074-9. PubMed ID: 2797067
[TBL] [Abstract][Full Text] [Related]
22. Serum leptin and adiponectin levels and risk of renal cell carcinoma.
Liao LM; Schwartz K; Pollak M; Graubard BI; Li Z; Ruterbusch J; Rothman N; Davis F; Wacholder S; Colt J; Chow WH; Purdue MP
Obesity (Silver Spring); 2013 Jul; 21(7):1478-85. PubMed ID: 23666639
[TBL] [Abstract][Full Text] [Related]
23. Race/ethnicity and advanced stage of renal cell carcinoma in adults: results from surveillance, epidemiology, and end results program 2007-2015.
Dobyns AC; Coutelle NA; Suthumphong CY; Rodriguez PE; Castro G; Varella MH
Eur J Cancer Prev; 2022 Mar; 31(2):172-177. PubMed ID: 34115692
[TBL] [Abstract][Full Text] [Related]
24. Incidence and predictors of end stage renal disease among low-income blacks and whites.
Lipworth L; Mumma MT; Cavanaugh KL; Edwards TL; Ikizler TA; Tarone RE; McLaughlin JK; Blot WJ
PLoS One; 2012; 7(10):e48407. PubMed ID: 23110237
[TBL] [Abstract][Full Text] [Related]
25. Rate of renal cell carcinoma subtypes in different races.
Sankin A; Cohen J; Wang H; Macchia RJ; Karanikolas N
Int Braz J Urol; 2011; 37(1):29-32;discussion 33-4. PubMed ID: 21385477
[TBL] [Abstract][Full Text] [Related]
26. Hematuria in sickle cell anemia--not always benign: evidence for excess frequency of sickle cell anemia in African Americans with renal cell carcinoma.
Baron BW; Mick R; Baron JM
Acta Haematol; 1994; 92(3):119-22. PubMed ID: 7871949
[TBL] [Abstract][Full Text] [Related]
27. Higher protein intake is associated with increased risk for incident end-stage renal disease among blacks with diabetes in the Southern Community Cohort Study.
Malhotra R; Cavanaugh KL; Blot WJ; Ikizler TA; Lipworth L; Kabagambe EK
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1079-1087. PubMed ID: 27562875
[TBL] [Abstract][Full Text] [Related]
28. Racial differences in the incidence of end-stage renal disease.
Tell GS; Hylander B; Craven TE; Burkart J
Ethn Health; 1996 Mar; 1(1):21-31. PubMed ID: 9395545
[TBL] [Abstract][Full Text] [Related]
29. Risk of Renal Cell Carcinoma Among Kidney Transplant Recipients in the United States.
Karami S; Yanik EL; Moore LE; Pfeiffer RM; Copeland G; Gonsalves L; Hernandez BY; Lynch CF; Pawlish K; Engels EA
Am J Transplant; 2016 Dec; 16(12):3479-3489. PubMed ID: 27160653
[TBL] [Abstract][Full Text] [Related]
30. Socioeconomic determinants of racial disparities in survival outcomes among patients with renal cell carcinoma.
Alam R; Rezaee ME; Pallauf M; Elias R; Yerrapragada A; Enikeev D; Fang D; Shariat SF; Woldu SL; Ged YMA; Singla N
Urol Oncol; 2023 Nov; 41(11):460.e1-460.e9. PubMed ID: 37709565
[TBL] [Abstract][Full Text] [Related]
31. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
[TBL] [Abstract][Full Text] [Related]
32. Racial Disparities and Preventive Measures to Renal Cell Carcinoma.
Sims JN; Yedjou CG; Abugri D; Payton M; Turner T; Miele L; Tchounwou PB
Int J Environ Res Public Health; 2018 May; 15(6):. PubMed ID: 29843394
[TBL] [Abstract][Full Text] [Related]
33. Racial disparities in end-stage renal disease in a high-risk population: the Southern Community Cohort Study.
Bock F; Stewart TG; Robinson-Cohen C; Morse J; Kabagambe EK; Cavanaugh KL; Birdwell KA; Hung AM; Abdel-Kader K; Siew ED; Akwo EA; Blot WJ; Ikizler TA; Lipworth L
BMC Nephrol; 2019 Aug; 20(1):308. PubMed ID: 31390993
[TBL] [Abstract][Full Text] [Related]
34. Renal cell carcinoma in dialysis patients: a single center experience.
Kojima Y; Takahara S; Miyake O; Nonomura N; Morimoto A; Mori H
Int J Urol; 2006 Aug; 13(8):1045-8. PubMed ID: 16903927
[TBL] [Abstract][Full Text] [Related]
35. Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus.
Stephens GW; Gillaspy JA; Clyne D; Mejia A; Pollak VE
Am J Kidney Dis; 1990 Jun; 15(6):562-7. PubMed ID: 2368696
[TBL] [Abstract][Full Text] [Related]
36. Neighborhood socioeconomic status, race, and mortality in young adult dialysis patients.
Johns TS; Estrella MM; Crews DC; Appel LJ; Anderson CA; Ephraim PL; Cook C; Boulware LE
J Am Soc Nephrol; 2014 Nov; 25(11):2649-57. PubMed ID: 24925723
[TBL] [Abstract][Full Text] [Related]
37. Rising incidence of renal cell cancer in the United States.
Chow WH; Devesa SS; Warren JL; Fraumeni JF
JAMA; 1999 May; 281(17):1628-31. PubMed ID: 10235157
[TBL] [Abstract][Full Text] [Related]
38. Analgesic use and risk of renal cell carcinoma: A case-control, cohort and meta-analytic assessment.
Karami S; Daughtery SE; Schwartz K; Davis FG; Ruterbusch JJ; Wacholder S; Graubard BI; Berndt SI; Hofmann JN; Purdue MP; Moore LE; Colt JS
Int J Cancer; 2016 Aug; 139(3):584-92. PubMed ID: 27009534
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts.
Truong H; Hegarty SE; Gomella LG; Kelly WK; Trabulsi EJ; Lallas CD; Giri VN
J Genet Couns; 2017 Jun; 26(3):548-555. PubMed ID: 28101821
[TBL] [Abstract][Full Text] [Related]
40. Incidence of atherosclerosis by race in the dialysis morbidity and mortality study: a sample of the US ESRD population.
Parekh RS; Zhang L; Fivush BA; Klag MJ
J Am Soc Nephrol; 2005 May; 16(5):1420-6. PubMed ID: 15788470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
